Nitrilotriacetic acid
Source Nitrilotriacetic acid at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Nitrilotriacetic acid (NTA) is a small tetradentate chelating agent that forms stable complexes with transition‑metal ions such as Ni²⁺ or Co²⁺. The resulting NTA‑metal complex binds with high (sub‑nanomolar) affinity to poly‑histidine (His‑tag) sequences on recombinant proteins. This reversible interaction underpins a range of research applications, including affinity purification, protein immobilisation, biosensor construction, and the recruitment of His‑tagged proteins to NTA‑functionalised lipids in in‑vitro autophagy assays.
Mechanism of Action
NTA coordinates a metal ion through its three carboxylate groups and a nitrogen donor, creating a square‑planar or octahedral NTA‑metal complex. The metal centre then serves as a docking site for the imidazole nitrogens of histidine residues, forming coordinate bonds that lock the His‑tagged protein in place. Because the metal‑histidine coordination is reversible, the protein can be released by adding excess imidazole or a competing chelator. When NTA is attached to lipids or surfaces, the same chemistry enables spatially controlled protein recruitment.
What the Research Shows
A series of reviews document the broad utility of NTA‑metal chemistry in biochemical research. You and Piehler (2014) described multivalent NTA chelators that graft multiple NTA units onto scaffolds, providing sub‑nanomolar, yet reversible, binding of His‑tagged proteins for immobilisation and labelling. Mu et al. (2014) incorporated NTA‑Ni²⁺ groups onto polymer‑coated carbon nanotubes, creating fluorescence‑based sensors capable of detecting His‑tagged lectins at nanomolar to picomolar levels. Zhu et al. (2023) summarized biosensor platforms (SPR, electrochemical, fluorescence, etc.) that exploit NTA‑metal complexes for protein capture. Huang et al. (2022) noted the use of DGS‑NTA lipids in reconstituted Atg8‑PE autophagy assays to recruit His‑tagged proteins to model membranes. The IARC monographs (1990, 1999) evaluated the carcinogenic risk of NTA and its salts, but the abstracts do not state a definitive classification, indicating that human risk data are limited.
Reported Benefits
NTA‑metal complexes offer exceptionally high affinity for His‑tags while remaining reversible, allowing gentle elution of purified proteins. The small size of NTA minimizes steric hindrance, and its chemistry is compatible with aqueous buffers, surfaces, and lipid bilayers. Multivalent NTA scaffolds increase binding avidity for sensor applications, and the approach is widely adopted for protein purification, immobilisation, and real‑time detection in biosensing platforms.
Limitations of the Evidence
NTA is primarily a research reagent and has no approved therapeutic indication. Effective binding requires pre‑loading with a suitable metal ion, and metal leaching can occur if conditions are not controlled. Specificity is limited to His‑tagged proteins; non‑His proteins are not captured. The IARC evaluations suggest insufficient evidence to rule out carcinogenic risk, highlighting a lack of long‑term safety data for human exposure. Consequently, NTA is not used in clinical settings.
Safety Considerations
NTA is a chelating agent that can bind essential metal ions; accidental ingestion or inhalation may disrupt metal homeostasis. The IARC monographs have examined its carcinogenic potential, but no conclusive hazard classification is provided, indicating uncertainty. Laboratory handling should follow standard chemical safety practices: wear gloves, eye protection, and work in a fume hood to avoid aerosol exposure. Dispose of NTA‑containing waste according to institutional hazardous waste guidelines.
How It Is Administered
NTA is supplied as a powder and dissolved in aqueous buffer to make a stock solution. For protein capture, the solution is mixed with a divalent metal ion (commonly Ni²⁺) to form the NTA‑metal complex, which is then immobilised on chromatography resins, sensor surfaces, or incorporated into lipid vesicles. The reagent is applied in vitro; there are no routes of administration for human use.
Routes of Administration
No administration routes recorded yet.
Goals & Uses
No goal associations recorded yet.
Contraindications
No contraindications recorded yet.
Adverse Effects
No adverse effects recorded yet.
Drug Interactions
No drug interactions recorded yet.
Population Constraints
No population constraints recorded yet.
Regulatory Status
No regulatory status recorded yet.
Evidence & Sources
- Journal ArticleModerateHuang X, et al.2022-01-01T00:00:00.000000Z
- Journal ArticleModerate1990-01-01T00:00:00.000000Z
- Journal ArticleModerateYou C, Piehler J2014-01-01T00:00:00.000000Z
- Journal ArticleModerateMu B, et al.2014-01-01T00:00:00.000000Z
- Journal ArticleModerateZhu L, et al.2023-01-01T00:00:00.000000Z
- Journal ArticleModerate1999-01-01T00:00:00.000000Z
Frequently Asked Questions
What is the main purpose of nitrilotriacetic acid in the laboratory?
NTA is used to chelate transition‑metal ions and create a binding site for poly‑histidine tags on recombinant proteins, enabling affinity purification, immobilisation, and detection in various assay formats.
Can NTA be used to purify any protein?
Only proteins engineered with a His‑tag can be captured by NTA‑metal complexes. Untagged proteins do not bind specifically and require alternative purification strategies.
Is NTA safe to handle in a typical chemistry lab?
NTA should be handled with standard protective equipment (gloves, goggles, fume hood) because it can chelate essential metals and its long‑term carcinogenic risk is not fully resolved. Avoid ingestion, inhalation, and skin contact.
Why are metal ions added to NTA before use?
The metal ion (e.g., Ni²⁺) occupies NTA’s coordination sites, creating a metal‑center that can form coordinate bonds with the imidazole nitrogens of histidine residues, which is essential for the high‑affinity His‑tag interaction.
Has nitrilotriacetic acid been evaluated for cancer risk?
The International Agency for Research on Cancer (IARC) has published monographs assessing NTA and its salts, but the abstracts do not provide a definitive classification, indicating that evidence for carcinogenicity in humans remains inconclusive.